Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD.

Witt KL, Shelby MD, Itchon-Ramos N, Faircloth M, Kissling GE, Chrisman AK, Ravi H, Murli H, Mattison DR, Kollins SH.

J Am Acad Child Adolesc Psychiatry. 2008 Dec;47(12):1375-83. doi: 10.1097/CHI.0b013e3181893620.

PMID:
18978633
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Cytogenetic effects in children treated with methylphenidate.

El-Zein RA, Abdel-Rahman SZ, Hay MJ, Lopez MS, Bondy ML, Morris DL, Legator MS.

Cancer Lett. 2005 Dec 18;230(2):284-91.

PMID:
16297714
[PubMed - indexed for MEDLINE]
3.

Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate.

Ponsa I, Ramos-Quiroga JA, Ribasés M, Bosch R, Bielsa A, Ordeig MT, Morell M, Miró R, de Cid R, Estivill X, Casas M, Bayés M, Cormand B, Hervás A.

Mutat Res. 2009 Jun 18;666(1-2):44-9. doi: 10.1016/j.mrfmmm.2009.03.014. Epub 2009 Apr 9.

PMID:
19457516
[PubMed - indexed for MEDLINE]
4.

Cytogenetic assessment of methylphenidate treatment in pediatric patients treated for attention deficit hyperactivity disorder.

Tucker JD, Suter W, Petibone DM, Thomas RA, Bailey NL, Zhou Y, Zhao Y, Muniz R, Kumar V.

Mutat Res. 2009 Jun-Jul;677(1-2):53-8. doi: 10.1016/j.mrgentox.2009.05.005. Epub 2009 May 22.

PMID:
19465145
[PubMed - indexed for MEDLINE]
5.

No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.

Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.

Toxicol Lett. 2009 Jan 10;184(1):38-43. doi: 10.1016/j.toxlet.2008.10.011. Epub 2008 Oct 28.

PMID:
19015014
[PubMed - indexed for MEDLINE]
6.

Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.

Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK.

Clin Ther. 2007 Jun;29(6):1168-77.

PMID:
17692731
[PubMed - indexed for MEDLINE]
7.

Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.

Preston RJ, Kollins SH, Swanson JM, Greenhill LL, Wigal T, Elliott GR, Vitiello B.

Cancer Lett. 2005 Dec 18;230(2):292-4. Epub 2005 Jul 12. No abstract available.

PMID:
16019134
[PubMed - indexed for MEDLINE]
8.

Methylphenidate and chromosome damage.

Jacobson-Kram D, Mattison D, Shelby M, Slikker W, Tice R, Witt K.

Cancer Lett. 2008 Feb 18;260(1-2):216-8. Epub 2007 Dec 4. No abstract available.

PMID:
18055105
[PubMed - indexed for MEDLINE]
9.

A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Pelham WE, Aronoff HR, Midlam JK, Shapiro CJ, Gnagy EM, Chronis AM, Onyango AN, Forehand G, Nguyen A, Waxmonsky J.

Pediatrics. 1999 Apr;103(4):e43.

PMID:
10103335
[PubMed - indexed for MEDLINE]
10.

Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children.

Walitza S, Kämpf K, Oli RG, Warnke A, Gerlach M, Stopper H.

Toxicol Lett. 2010 Mar 1;193(1):4-8. doi: 10.1016/j.toxlet.2009.12.013. Epub 2009 Dec 22. Review.

PMID:
20026394
[PubMed - indexed for MEDLINE]
11.

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

J Manag Care Pharm. 2007 Sep;13(7):561-9.

PMID:
17874862
[PubMed - indexed for MEDLINE]
Free Article
12.

Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder.

Pliszka SR, Matthews TL, Braslow KJ, Watson MA.

J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):520-6.

PMID:
16670648
[PubMed - indexed for MEDLINE]
13.

24-hour ambulatory blood pressure monitoring in male children receiving stimulant therapy.

Stowe CD, Gardner SF, Gist CC, Schulz EG, Wells TG.

Ann Pharmacother. 2002 Jul-Aug;36(7-8):1142-9.

PMID:
12086544
[PubMed - indexed for MEDLINE]
14.

Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.

Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.

Clin Ther. 2009 Aug;31(8):1844-55. doi: 10.1016/j.clinthera.2009.08.002.

PMID:
19808143
[PubMed - indexed for MEDLINE]
15.
16.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
[PubMed - indexed for MEDLINE]
17.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
[PubMed - indexed for MEDLINE]
19.

Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).

Kollins SH, Shapiro SK, Newland MC, Abramowitz A.

Exp Clin Psychopharmacol. 1998 Nov;6(4):375-89.

PMID:
9861552
[PubMed - indexed for MEDLINE]
20.

Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.

Wilens TE, Hammerness PG, Biederman J, Kwon A, Spencer TJ, Clark S, Scott M, Podolski A, Ditterline JW, Morris MC, Moore H.

J Clin Psychiatry. 2005 Feb;66(2):253-9.

PMID:
15705013
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk